secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sight Sciences, Inc. (SGHT)
CIK:        0001531177
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0000950170-24-066276
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sight Sciences: Draft Medicare LCDs propose no coverage restrictions for OMNI and SION
--------------------------------------------------------------------------------

- Five MACs published draft LCDs on MIGS not proposing specific coverage criteria for OMNI (canaloplasty+trabeculotomy) or SION (goniotomy).
- These procedures would remain eligible for Medicare in states covering 62% of Sight Sciences' 2023 Surgical Glaucoma revenue.
- Draft LCDs propose non-coverage when an aqueous shunt/stent is performed with a MIGS procedure in the same eye at same time.
- 45-day comment period; finalization within 365 days. Company plans to engage with MACs, CMS, and clinical societies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531177/000095017024066276/0000950170-24-066276-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531177/000095017024066276/sght-20240530.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-066276

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer